JP2001518459A - 葉酸拮抗剤を作成するのに有用な方法及び中間体 - Google Patents

葉酸拮抗剤を作成するのに有用な方法及び中間体

Info

Publication number
JP2001518459A
JP2001518459A JP2000513828A JP2000513828A JP2001518459A JP 2001518459 A JP2001518459 A JP 2001518459A JP 2000513828 A JP2000513828 A JP 2000513828A JP 2000513828 A JP2000513828 A JP 2000513828A JP 2001518459 A JP2001518459 A JP 2001518459A
Authority
JP
Japan
Prior art keywords
compound
formula
bond
nhc
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000513828A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001518459A5 (enExample
Inventor
ダグラス・パットン・クジェル
ブライアン・ジェイムズ・スラットリー
チャールズ・ジャクソン・バーネット
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26786718&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP2001518459(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of JP2001518459A publication Critical patent/JP2001518459A/ja
Publication of JP2001518459A5 publication Critical patent/JP2001518459A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/24—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of a carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Cephalosporin Compounds (AREA)
JP2000513828A 1997-09-26 1998-09-18 葉酸拮抗剤を作成するのに有用な方法及び中間体 Pending JP2001518459A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US93838597A 1997-09-26 1997-09-26
US9303997P 1997-09-26 1997-09-26
US60/093,039 1997-09-26
US08/938,385 1997-09-26
PCT/US1998/019560 WO1999016742A1 (en) 1997-09-26 1998-09-18 Processes and intermediates useful to make antifolates

Publications (2)

Publication Number Publication Date
JP2001518459A true JP2001518459A (ja) 2001-10-16
JP2001518459A5 JP2001518459A5 (enExample) 2006-01-05

Family

ID=26786718

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000513828A Pending JP2001518459A (ja) 1997-09-26 1998-09-18 葉酸拮抗剤を作成するのに有用な方法及び中間体

Country Status (18)

Country Link
US (1) US6013828A (enExample)
JP (1) JP2001518459A (enExample)
KR (1) KR20010030712A (enExample)
CN (2) CN1246295C (enExample)
AU (1) AU740087B2 (enExample)
BR (1) BR9812524A (enExample)
CA (1) CA2304656A1 (enExample)
CZ (1) CZ301563B6 (enExample)
EA (1) EA002452B3 (enExample)
HU (1) HUP0003954A3 (enExample)
ID (1) ID24165A (enExample)
IL (1) IL135190A (enExample)
NO (2) NO314456B1 (enExample)
NZ (1) NZ503600A (enExample)
PL (1) PL196216B1 (enExample)
TR (1) TR200001220T2 (enExample)
UA (1) UA53742C2 (enExample)
WO (1) WO1999016742A1 (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008543974A (ja) * 2006-08-14 2008-12-04 シコール インコーポレイティド ペメトレキセド二酸の結晶形およびその調製方法
JP2008543975A (ja) * 2006-08-14 2008-12-04 シコール インコーポレイティド 高度に純粋なペメトレキセド二酸およびその調製方法
JP2012502933A (ja) * 2008-09-22 2012-02-02 重▲慶▼医葯工▲業▼研究院有限責任公司 ペメトレキセド二酸の新規結晶型及びその製造方法
JP2016531925A (ja) * 2013-09-05 2016-10-13 サムヤン バイオファーマシューティカルズ コーポレイション ペメトレキセド製造のための中間体製造方法及びこれを用いて高純度ペメトレキセドを製造する方法

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6890800A (en) * 1999-08-23 2001-03-19 Eli Lilly And Company A novel crystalline form of disodium n-[4-[2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo[2,3-D]- pyrimidin-5-yl)ethyl]benzoyl]-l-glutamic acid salt and processes therefor
EP1259513B1 (en) * 2000-02-25 2003-09-10 Eli Lilly And Company A NOVEL CRYSTALLINE FORM OF N- 4- 2-(2-AMINO-4,7-DIHYDRO-4-OXO-3H-PYRROLO 2,3-d]PYRIMIDIN-5-YL)ETHYL]BENZOYL]-L-GLUTAMIC ACID AND PROCESS THEREFOR
CN100379729C (zh) * 2006-04-06 2008-04-09 海南天源康泽医药科技有限公司 硝基化合物及其在培美曲塞制备中的应用
CN101687872A (zh) * 2007-04-03 2010-03-31 雷迪博士实验室有限公司 培美曲塞的固体形式
CN101417998B (zh) 2007-10-24 2012-10-24 重庆医药工业研究院有限责任公司 一种培美曲塞盐的纯化方法
CN101591247B (zh) * 2008-05-30 2012-09-05 上海希迪制药有限公司 合成4-(4-甲酯基苯基)丁醛的方法
US9174991B2 (en) 2009-11-24 2015-11-03 Azad Pharmaceutical Ingredients Ag Crystalline form of pemetrexed disodium
IT1401677B1 (it) * 2010-07-22 2013-08-02 Chemi Spa Nuovo processo per la sintesi di pemetrexed sale disodico
UA105580C2 (uk) 2010-08-02 2014-05-26 Неон Лабораторіс Лтд. Спосіб одержання діалкілпеметрекседу високої чистоти
WO2012111027A2 (en) * 2011-02-15 2012-08-23 Hetero Research Foundation Process for pemetrexed disodium
US9051322B2 (en) 2011-03-23 2015-06-09 Scinopharm Taiwan, Ltd. Process for the production of a pemetrexed salt
ES2639639T3 (es) * 2011-03-25 2017-10-27 Scinopharm Taiwan, Ltd. Proceso para la producción de pemetrexed disódico
WO2012150280A2 (en) 2011-05-05 2012-11-08 Lonza Ltd Preparation of 4,4-dialkoxy-1-buten-1-ylarenes
CN102887902B (zh) * 2012-10-10 2015-05-20 北京莱瑞森医药科技有限公司 一种合成高纯度培美酸的制备工艺
CN102911176B (zh) * 2012-10-10 2015-07-22 德州德药制药有限公司 一种培美曲塞二钠的制备方法
NZ630292A (en) 2013-11-25 2015-02-27 Shilpa Medicare Ltd Process for crystalline pemetrexed dipotassium salt
CN104817563B (zh) * 2015-05-11 2017-10-27 宁波美诺华药业股份有限公司 培美曲塞‑n,n‑二苄基乙二胺盐的制备方法
CN109836425B (zh) * 2017-11-24 2023-01-24 江苏创诺制药有限公司 一种合成培美酸的制备工艺
CN109721604B (zh) * 2019-01-25 2021-03-23 南京亚东启天药业有限公司 培美曲塞酸的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4895946A (en) * 1987-10-26 1990-01-23 The Trustees Of Princeton University Process for the preparation of fused pyridine compounds
NO169490C (no) * 1988-03-24 1992-07-01 Takeda Chemical Industries Ltd Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolopyrimidinderivater
JP2983254B2 (ja) * 1989-06-14 1999-11-29 武田薬品工業株式会社 ピロロ〔２，３―ｄ〕ピリミジン誘導体の製造法およびその中間体
EP0438261A3 (en) * 1990-01-16 1992-02-26 Takeda Chemical Industries, Ltd. Condensed heterocyclic glutamic acid derivatives, their production and use
CZ283281B6 (cs) * 1992-09-25 1998-02-18 Eli Lilly And Company Způsob přípravy v poloze 5 substituovaných pyrrolo(2,3-d)pyrimidinů
US5416211A (en) * 1992-09-25 1995-05-16 Eli Lilly And Company Process for preparing 5-substituted pyrrolo-[2,3-d]pyrimidines
CZ283345B6 (cs) * 1993-05-24 1998-03-18 Eli Lilly And Company Způsob přípravy v poloze 5 substituovaného derivátu pyrrolo [2,3-d]pyrimidinu

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008543974A (ja) * 2006-08-14 2008-12-04 シコール インコーポレイティド ペメトレキセド二酸の結晶形およびその調製方法
JP2008543975A (ja) * 2006-08-14 2008-12-04 シコール インコーポレイティド 高度に純粋なペメトレキセド二酸およびその調製方法
JP2012502933A (ja) * 2008-09-22 2012-02-02 重▲慶▼医葯工▲業▼研究院有限責任公司 ペメトレキセド二酸の新規結晶型及びその製造方法
JP2016531925A (ja) * 2013-09-05 2016-10-13 サムヤン バイオファーマシューティカルズ コーポレイション ペメトレキセド製造のための中間体製造方法及びこれを用いて高純度ペメトレキセドを製造する方法

Also Published As

Publication number Publication date
PL196216B1 (pl) 2007-12-31
CA2304656A1 (en) 1999-04-08
KR20010030712A (ko) 2001-04-16
EA200000359A1 (ru) 2000-10-30
BR9812524A (pt) 2000-07-25
NO20001554D0 (no) 2000-03-24
PL339452A1 (en) 2000-12-18
US6013828A (en) 2000-01-11
HUP0003954A2 (hu) 2001-09-28
EA002452B3 (ru) 2018-02-28
NO2005007I1 (no) 2005-04-04
TR200001220T2 (tr) 2001-05-21
EA002452B1 (ru) 2002-04-25
NO314456B1 (no) 2003-03-24
CN1271338A (zh) 2000-10-25
NO2005007I2 (no) 2008-02-11
CN1213998C (zh) 2005-08-10
IL135190A0 (en) 2001-05-20
CZ301563B6 (cs) 2010-04-14
AU9493798A (en) 1999-04-23
AU740087B2 (en) 2001-11-01
CN1246295C (zh) 2006-03-22
WO1999016742A1 (en) 1999-04-08
NO20001554L (no) 2000-05-24
CN1475477A (zh) 2004-02-18
HUP0003954A3 (en) 2002-12-28
IL135190A (en) 2005-03-20
NZ503600A (en) 2001-08-31
UA53742C2 (uk) 2003-02-17
ID24165A (id) 2000-07-13

Similar Documents

Publication Publication Date Title
JP2001518459A (ja) 葉酸拮抗剤を作成するのに有用な方法及び中間体
US6262262B1 (en) Processes and intermediates useful to make antifolates
JP2001519353A (ja) ヒドロキシ酢酸エステル誘導体、その製法及び合成中間体としての用途
JPS6339868A (ja) ジ低級アルキルフエノ−ル誘導体
CN113272290A (zh) 用于沃塞洛托合成的方法和中间体
EP0905128B1 (en) Processes and intermediates useful to make antifolates
JP2003506425A (ja) ナプロキセンのニトロキシアルキルエステルの製造法
JP4528123B2 (ja) ナプロキセンのニトロオキシ誘導体の製造法
JP3452081B2 (ja) フルオロ−トリフルオロメチル安息香酸誘導体類
JP4771659B2 (ja) 新規な方法
US6090168A (en) Processes and intermediates useful to make antifolates
JP2003286244A (ja) Ｎ−フェニルビス（トリフルオロメタンスルホンイミド）の製造方法
JPH0742269B2 (ja) ４−アルコキシ−３−ピロリン−２−オン−１−イル−酢酸アルキルエステルおよびその製造方法
JP2001512098A (ja) ３−シアノ−２，４−ジハロゲノ−５−フルオロ安息香酸の製造方法
HK1020437B (en) Processes and intermediates useful to make antifolates
JP3573249B2 (ja) ２，３，４−トリフルオロ−５−ヨ−ド安息香酸、そのエステル類及びその製造法
JP2547634B2 (ja) ２ーアシルー２ーアリールオキシ又はヘテロ環オキシアセトニトリル類およびアミノピラゾール類の製造方法
JP2603108B2 (ja) アニリノピリミジン誘導体
MXPA00002872A (en) Processes and intermediates useful to make antifolates
CZ20001040A3 (cs) Způsoby a meziprodukty pro přípravu antifolátů
JP3646225B2 (ja) 芳香族エステル誘導体及びその中間体並びにそれらの製造方法
JP2500316B2 (ja) １，４，５，８―テトラキス（ハロゲノメチル）ナフタレン誘導体、およびその製造方法
JPH0576473B2 (enExample)
JPH03153660A (ja) ４―ハロ―３―ヒドロキシブタンニトリルのスルホン酸エステルおよびその製造法
JPS5995260A (ja) スルホン酸エステル誘導体

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050614

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050614

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080624

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20081224